Connecticut Attorney General Announces Settlement for Generic Drug Price-Fixing Claims Connecticut's Attorney General reveals new settlements with generic drug manufacturers for illegal price-fixing practices affecting consumers' expenses.

Connecticut Attorney General Announces Settlement for Generic Drug Price-Fixing Claims #Settlement #Connecticut #Generic_Drugs

Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers Recent settlements in Connecticut allow consumers who purchased generic drugs to receive payments for overinflated prices. Details outlined.

Connecticut Settles with Generic Drug Makers Over Pricing Allegations Impacting Consumers #United_States #Hartford #Generic_Drugs #Bausch_Health #Lannett_Company

Upcoming Commemorative Seminar for Generic Pharmaceuticals Day on December 22, 2023 Join us on December 22 for an insightful discussion on the state of generic pharmaceuticals and their impact on healthcare today. Entry is free.

Upcoming Commemorative Seminar for Generic Pharmaceuticals Day on December 22, 2023 #Japan #Tokyo #pharmaceuticals #Generic_Drugs #GEDA

Global Generic Drugs Market Expected to Reach USD 898 Billion by 2035, Driven by Diverse Growth Factors The global generic drugs market is projected to grow from USD 487.21 billion in 2024 to USD 898 billion by 2035. Factors include patent expirations and rising chronic diseases.

Global Generic Drugs Market Expected to Reach USD 898 Billion by 2035, Driven by Diverse Growth Factors #USA #New_York #pharmaceuticals #Generic_Drugs #Vantage_Market_Research

Par Health Emerges as Independent Leader in Generic Pharmaceuticals and Sterile Injectables Par Health has successfully spun off from Mallinckrodt, establishing itself as a top U.S. player in generic drugs and sterile injectables, poised for growth.

Par Health Emerges as Independent Leader in Generic Pharmaceuticals and Sterile Injectables #United_States #St._Louis #pharmaceuticals #Generic_Drugs #Par_Health

Class Action Settlement for Prescription Generic Drug Users in the U.S. Revealed A significant legal notice details a class action settlement for individuals who paid for certain prescription generic drugs in the U.S. from May 2009 to December 2019.

Class Action Settlement for Prescription Generic Drug Users in the U.S. Revealed #USA #Class_Action #Philadelphia #Settlement #Generic_Drugs

Fine, Kaplan and Black Announces Settlement in Class Action for Prescription Drug Payments Fine, Kaplan and Black, R.P.C. has announced a settlement in a class action lawsuit for those who incurred costs for certain prescription generic drugs between 2009 and 2019.

Fine, Kaplan and Black Announces Settlement in Class Action for Prescription Drug Payments #United_States #Class_Action #Philadelphia #Lawsuit #Generic_Drugs

Class Action Settlement Announced for Prescription Generic Drugs in the USA A federal court has authorized a $200 million class action settlement related to certain prescription generic drugs. Eligible individuals can make claims if they paid or reimbursed for these drugs in the U.S. between 2009 and 2019.

Class Action Settlement Announced for Prescription Generic Drugs in the USA #United_States #Class_Action #Philadelphia #Generic_Drugs #Antitrust_Laws

Settlement Announcement for Class Action on Prescription Generic Drugs in the US A legal notice about a class action settlement available for individuals who paid for specific prescription generic drugs from 2009 to 2019 in the U.S.

Settlement Announcement for Class Action on Prescription Generic Drugs in the US #USA #Class_Action #Philadelphia #Settlement #Generic_Drugs

NastLaw LLC and Plaintiffs Announce New Settlements in Antitrust Case Against Generic Pharmaceutical Pricing NastLaw LLC and Direct Purchaser Plaintiffs have announced proposed settlements in a significant antitrust case regarding pricing of generic pharmaceuticals, impacting many buyers.

NastLaw LLC and Plaintiffs Announce New Settlements in Antitrust Case Against Generic Pharmaceutical Pricing #USA #Philadelphia #Generic_Drugs #Antitrust #NastLaw

Connecticut Attorney General Announces Settlement with Apotex for Inflating Generic Drug Prices Consumers who purchased certain generic drugs may be eligible for compensation due to a recent settlement with Apotex Corp., concerning price-fixing conspiracies.

Connecticut Attorney General Announces Settlement with Apotex for Inflating Generic Drug Prices #USA #Hartford #Generic_Drugs #Price-Fixing #Apotex_Corp

Preliminary Settlement Approved with Apotex Corp for Price Manipulation in U.S. Prescription Market Consumers who purchased specific generic prescription drugs between 2009 and 2019 may be eligible for compensation due to a settlement with Apotex Corp in price manipulation cases.

Preliminary Settlement Approved with Apotex Corp for Price Manipulation in U.S. Prescription Market #United_States #Hartford #Generic_Drugs #Apotex_Corp #Price_Manipulation

Settlement Approved for Consumers Affected by Apotex's Price Manipulation of Generic Drugs Consumers who purchased specific generic drugs between 2009 and 2019 may be eligible for compensation from a newly approved settlement with Apotex Corp.

Settlement Approved for Consumers Affected by Apotex's Price Manipulation of Generic Drugs #USA #Hartford #Generic_Drugs #Apotex_Corp #Price_Manipulation

Settlement of $275 Million Class Action to Aid Consumers in Prescription Drug Prices A historic $275 million class action settlement has been announced, aimed at assisting consumers and third-party payers who overpaid for generic prescription drugs. Eligible parties can claim their share under court settlement.

Settlement of $275 Million Class Action to Aid Consumers in Prescription Drug Prices #USA #Class_Action #Philadelphia #Health_Care #Generic_Drugs

Final Claimants Announce $275 Million Class Action Settlement for Consumers in Generic Drug Case A recent class action lawsuit over generic prescription drugs results in a $275 million settlement, benefiting consumers and payers.

Final Claimants Announce $275 Million Class Action Settlement for Consumers in Generic Drug Case #United_States #Class_Action #Philadelphia #Settlement #Generic_Drugs

Court Approves Settlements in Lawsuit Against Generic Drug Makers for Price Inflation and Competition Limitation A U.S. district court has approved preliminary settlements in a monumental lawsuit against generic drug manufacturers accused of inflating prices for consumers, affecting numerous medications.

Court Approves Settlements in Lawsuit Against Generic Drug Makers for Price Inflation and Competition Limitation #United_States #Generic_Drugs #Price_Inflation #Settlements #Hartford,_Connecticut

Preliminary Approval of Settlements in Generic Drug Price Fixing Litigation by US District Court A US District Court has approved preliminary settlements involving generic drug manufacturers accused of price-fixing, affecting millions of consumers.

Preliminary Approval of Settlements in Generic Drug Price Fixing Litigation by US District Court #United_States #Hartford #Settlement #Generic_Drugs #Price_Fixing

Preliminary Approval Granted for Settlements Against Generic Drug Price Fixing in U.S. Courts Recent court approvals allow settlements against certain generic drug manufacturers involved in price-fixing conspiracies, impacting consumers significantly from 2010 to 2018.

Preliminary Approval Granted for Settlements Against Generic Drug Price Fixing in U.S. Courts #United_States #Hartford #Generic_Drugs #Heritage_Pharmaceuticals #Emcure_Pharmaceuticals

Zentiva's European Health Check Highlights Need for Generic Drug Reform The European Health Check by Zentiva revealed concerns regarding the sustainability of the generic drug framework, emphasizing the need for reforms to ensure drug accessibility.

Zentiva's European Health Check Highlights Need for Generic Drug Reform #None #Zentiva #Health_Check #Generic_Drugs

Zentiva's European Health Check Highlights Urgent Need for Reform in Generic Drug Framework A recent survey by Zentiva during the European Health Check showed that 77% of participants doubt the sustainability of the current generic drug system, urging reforms to ensure accessibility.

Zentiva's European Health Check Highlights Urgent Need for Reform in Generic Drug Framework #Zentiva #Czech_Republic #Prague #European_Health_Check #Generic_Drugs